Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Bayer to launch cancer research site in Cambridge
by Ryan Cross
April 12, 2019
| A version of this story appeared in
Volume 97, Issue 15
Last fall, Bayer announced it would lay off 12,000 employees worldwide. In a tiny offset, the firm is now making plans for a cancer research center in Cambridge, Massachusetts. Bayer will pay the Massachusetts Institute of Technology about $100 million for a 12-year lease of nearly 5,800 m2 of lab and office space in a new building in Kendall Square, the city’s biotech hub. Bayer has 20 employees in Cambridge and plans to add 75 to the new site when it opens in 2021. The number could double to 150 the following year.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter